Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Oncogene|April 13, 2005
In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell typeStefania Benini, Bernard Perbal, Diana Zambelli, et al.European Journal of Cancer (Oxford, England : 1990)|September 6, 2005
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patientsMichela Pasello, Claudia Maria Hattinger, Giuseppina Stoico, et al.Oxidative Medicine and Cellular Longevity|January 5, 2019
Oxidative Stress in Autistic Children Alters Erythrocyte Shape in the Absence of Quantitative Protein Alterations and of Loss of Membrane Phospholipid AsymmetryAlessandra Bolotta, Michela Battistelli, Elisabetta Falcieri, et al.Cancer Letters|November 23, 2006
Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cellsMaria Serena Benassi, Antonella Chiechi, Francesca Ponticelli, et al.Bone|March 31, 2004
Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase geneCinzia Zucchini, Michele Bianchini, Luisa Valvassori, et al.International Journal of Oncology|November 8, 2006
May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocolMassimo Serra, Michela Pasello, Maria Cristina Manara, et al.Journal of Cell Communication and Signaling|November 11, 2024
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscapeMichela Pasello, Maria Antonella Laginestra, Maria Cristina Manara, et al.European Journal of Cancer (Oxford, England : 1990)|December 6, 2005
Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcomaKatia Scotlandi, Stefania Perdichizzi, Ghislaine Bernard, et al.International Journal of Cancer|September 5, 2002
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsKatia Scotlandi, Sofia Avnet, Stefania Benini, et al.Oncotarget|April 25, 2015
ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agentsCaterina Mancarella, Irene Casanova-Salas, Ana Calatrava, et al.Pageof 8